Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice

被引:28
作者
Sun, DX [1 ]
Krishnan, A [1 ]
Su, JR [1 ]
Lawrence, R [1 ]
Zaman, K [1 ]
Fernandes, G [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Immunol, San Antonio, TX 78229 USA
关键词
SLE; T cells; cytokines; cyclophosphamide; calorie restriction;
D O I
10.1016/j.cellimm.2004.04.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We compared the effects of calorie restriction (CR) and cyclophosphamide (CTX) on the progression of lupus nephritis and immunological changes in NZB/NZW F1 mice. Ad libitum (AL)/CTX and CR delayed onset of proteinuria and significantly decreased serum levels of anti-dsDNA, anti-histone, and circulating immune complex antibodies. CTX and CR prevented the increase in and activation of B cells, the decline in CD8(+) T cells, and maintained a higher proportion of naive CD4(+) and CD8(+) cells. MHC class I antigen and LFA-1 expression on CD8(+) T cells and MHC class II antigen on B cells were also decreased. AL/CTX and CR prevented the increase in production of IL-10 and up-regulated IL-2 production in T cells ex vivo. We concluded that both CR and CTX can delay the onset of autoimmune disease, in part by maintaining higher numbers of naive T cells and the immune responsiveness of T cells and decreasing the proportion of B cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:54 / 65
页数:12
相关论文
共 66 条
  • [1] TREATMENT OF (NZBXNZW)F1 DISEASE WITH ANTI-I-A MONOCLONAL-ANTIBODIES
    ADELMAN, NE
    WATLING, DL
    MCDEVITT, HO
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (04) : 1350 - 1355
  • [2] CYTOKINE PROFILE IN SYSTEMIC LUPUS-ERYTHEMATOSUS, RHEUMATOID-ARTHRITIS, AND OTHER RHEUMATIC DISEASES
    ALJANADI, M
    ALBALLA, S
    ALDALAAN, A
    RAZIUDDIN, S
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1993, 13 (01) : 58 - 67
  • [3] ANALYSIS OF T-CELL FUNCTION IN AUTOIMMUNE MURINE STRAINS - DEFECTS IN PRODUCTION OF AND RESPONSIVENESS TO INTERLEUKIN-2
    ALTMAN, A
    THEOFILOPOULOS, AN
    WEINER, R
    KATZ, DH
    DIXON, FJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (03) : 791 - 808
  • [4] ANDO DG, 1987, J IMMUNOL, V138, P3185
  • [5] Premature coronary-artery atherosclerosis in systemic lupus erythematosus
    Asanuma, Y
    Oeser, A
    Shintani, AK
    Turner, E
    Olsen, N
    Fazio, S
    Linton, MF
    Raggi, P
    Stein, CM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) : 2407 - 2415
  • [6] Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmune-prone NZB/W female mice
    Bhattacharya, A
    Lawrence, RA
    Krishnan, A
    Zaman, K
    Sun, DX
    Fernandes, G
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2003, 22 (05) : 388 - 399
  • [7] INSITU CHARACTERIZATION OF AUTOIMMUNE PHENOMENA AND EXPRESSION OF HLA MOLECULES IN THE PANCREAS IN DIABETIC INSULITIS
    BOTTAZZO, GF
    DEAN, BM
    MCNALLY, JM
    MACKAY, EH
    SWIFT, PGF
    GAMBLE, DR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (06) : 353 - 360
  • [8] IMMUNOSUPPRESSION BY CYCLOPHOSPHAMIDE IN NZB X NZW MICE WITH LUPUS NEPHRITIS
    CASEY, TP
    [J]. BLOOD, 1968, 32 (03) : 436 - &
  • [9] Cutting edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide
    Daikh, DI
    Wofsy, D
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05) : 2913 - 2916
  • [10] DAUPHINEE MJ, 1981, J IMMUNOL, V127, P2483